Metropolitan Life Insurance Company (MetLife)’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,242
| Closed | -$81.9K | – | 84 |
|
|
2024
Q1 | $81.9K | Buy |
3,242
+263
| +9% | +$6.64K | ﹤0.01% | 1160 |
|
|
2023
Q4 | $69.6K | Hold |
2,979
| – | – | ﹤0.01% | 1273 |
|
|
2023
Q3 | $151K | Buy |
2,979
+525
| +21% | +$26.6K | 0.01% | 810 |
|
|
2023
Q2 | $115K | Buy |
2,454
+473
| +24% | +$22.1K | 0.01% | 951 |
|
|
2023
Q1 | $75.8K | Sell |
1,981
-175
| -8% | -$6.7K | ﹤0.01% | 1156 |
|
|
2022
Q4 | $118K | Buy |
2,156
+380
| +21% | +$20.8K | 0.01% | 967 |
|
|
2022
Q3 | $60.5K | Hold |
1,776
| – | – | ﹤0.01% | 1326 |
|
|
2022
Q2 | $16.8K | Hold |
1,776
| – | – | ﹤0.01% | 2124 |
|
|
2022
Q1 | $25.2K | Sell |
1,776
-5,750
| -76% | -$81.6K | ﹤0.01% | 1982 |
|
|
2021
Q4 | $159K | Hold |
7,526
| – | – | ﹤0.01% | 2183 |
|
|
2021
Q3 | $168K | Hold |
7,526
| – | – | ﹤0.01% | 2205 |
|
|
2021
Q2 | $187K | Buy |
7,526
+3,666
| +95% | +$91K | ﹤0.01% | 2196 |
|
|
2021
Q1 | $112K | Hold |
3,860
| – | – | ﹤0.01% | 2375 |
|
|
2020
Q4 | $99.6K | Hold |
3,860
| – | – | ﹤0.01% | 2361 |
|
|
2020
Q3 | $119K | Hold |
3,860
| – | – | ﹤0.01% | 2117 |
|
|
2020
Q2 | $96.2K | Buy |
+3,860
| New | +$96.2K | ﹤0.01% | 2273 |
|